Hemosate Ultra Hs4125 49.5 g (Dextrose SOLUTION) 49.5 G

HEMOSATE ULTRA HS4125 49.5 G is a dextrose solution designed for haemodialysis. This sterile solution is formulated to support medical procedures requiring precise dextrose levels. Ideal for healthcare professionals seeking reliable dialysis solutions.

Strength

49.5 G

Manufacturer / TM Owner

CHIEF MEDICAL SUPPLIES LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

HEMOSATE ULTRA HS4125 49.5 G is primarily used in haemodialysis to maintain appropriate dextrose levels in the blood. This solution is designed to support the dialysis process, ensuring that patients receive the necessary dextrose during treatment. It is commonly used in medical settings where precise control of blood glucose levels is required.

Side Effects

When used as directed, HEMOSATE ULTRA HS4125 49.5 G helps to maintain stable dextrose levels in the blood during haemodialysis. This can contribute to overall patient comfort and effectiveness of the dialysis procedure. As with any medical solution, individual responses may vary.

Precautions & Warnings

HEMOSATE ULTRA HS4125 49.5 G should be handled with care to maintain sterility. It is important to follow proper storage and usage guidelines to ensure safety. Always consult healthcare professionals for specific instructions and precautions related to haemodialysis solutions.

Avoid Interactions

HEMOSATE ULTRA HS4125 49.5 G should be used as directed by healthcare professionals. It is important to inform your healthcare provider about any other medications or supplements you are taking to avoid potential interactions. Always follow the advice of your healthcare provider regarding the use of haemodialysis solutions.

Frequently Asked Questions

HEMOSATE ULTRA HS4125 49.5 G is used in haemodialysis to maintain appropriate dextrose levels in the blood.

HEMOSATE ULTRA HS4125 49.5 G should be stored according to the manufacturer's guidelines to maintain sterility and effectiveness.

Consult your healthcare provider before using HEMOSATE ULTRA HS4125 49.5 G with other medications to avoid potential interactions.

HEMOSATE ULTRA HS4125 49.5 G helps to maintain stable dextrose levels during haemodialysis, contributing to patient comfort and treatment effectiveness.

HEMOSATE ULTRA HS4125 49.5 G is manufactured by Chief Medical Supplies Ltd.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.